Safety of Itacitinib in Combination With Corticosteroids for Treatment of Steroid-Naive Acute Graft-Versus-Host Disease in Japanese Subjects

NCT03497273 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

14

Enrollment

INDUSTRY

Sponsor class

Conditions

Acute Graft-versus-host Disease

Interventions

DRUG: Itacitinib
DRUG: Corticosteroid

Sponsor

Incyte Corporation